N/A N=50 Randomized Double-blind Screening

Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Health Behavior · Colorectal Cancer · Influenza · COVID-19 · Vaccine Hesitancy

Bottom Line

View on ClinicalTrials.gov: NCT06124131 ↗

Enrolled (actual)

Serious AEs

—

Results posted

May 2025

Primary outcome: Primary: Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms — 17; 8 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Financial incentive for colorectal cancer screening (Behavioral); Financial incentive for flu shot (Behavioral); Financial incentive for COVID-19 shot (Behavioral)
Age: Adult, Older Adult · 45+ yrs
Sex: All
Sponsor: Tulane University
Primary completion: Mar 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms	17; 8	—
SECONDARY Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms	1; 0	—
SECONDARY Difference in Percent of Participants Completing Flu Shot Between Study Arms	9; 10	—
SECONDARY Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	20; 13	—
SECONDARY Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	1; 0	—

Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Eligibility Criteria

Inclusion Criteria

Age 45 to 75
Receive care at participating primary care clinic
Due for colorectal cancer screening
Ability to understand and speak English

Exclusion Criteria

Currently participating in another clinical trial or research study on colorectal cancer screening
Unable or unwilling to give informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06124131). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.